Showing results (421-430 of 432) with videos related to
Sort By:
Pageof 44
Cancer Discovery|July 20, 2021
Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary CancerChiara Falcomatà, Stefanie Bärthel, Angelika Ulrich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2024
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III TrialDaniel H Palmer, Richard Jackson, Christoph Springfeld, et al.Journal of the American Society of Nephrology : JASN|September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant RecipientsChristian Morath, Matthias Schaier, Eman Ibrahim, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 28, 2020
Should kidney allografts from old donors be allocated only to old recipients?Caner Süsal, Gizem Kumru, Bernd Döhler, et al.Annals of Surgery|January 24, 2020
How to Handle Arterial Conduits in Liver Transplantation? Evidence From the First Multicenter Risk AnalysisChristian E Oberkofler, Dimitri A Raptis, Joseph DiNorcia, et al.BMJ Open|November 11, 2022
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trialChristian Morath, Anita Schmitt, Michael Schmitt, et al.Hepatology (Baltimore, Md.)|January 12, 2020
Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic OpportunitiesBenjamin Goeppert, Trine Folseraas, Stephanie Roessler, et al.Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.Annals of Surgery|July 24, 2023
Liver Histology Predicts Liver Regeneration and Outcome in ALPPS: Novel Findings From A Multicenter StudyVictor Lopez-Lopez, Michael Linecker, Albert Caballero-Llanes, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 23, 2022
Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantationChristian E Oberkofler, Dimitri A Raptis, Philip C Müller, et al.Pageof 44